New drug tested for deadly Pneumonia-Sepsis combo
NCT ID NCT06669403
Summary
This early-stage study is testing a new drug called OPT101 in adults hospitalized with pneumonia that has led to sepsis, a life-threatening body-wide infection. The main goal is to check if the drug is safe and how the body processes it. About 26 participants will receive either the drug or a placebo for up to 4 days while being treated in the hospital.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Denver Health and Hospital Authority
Denver, Colorado, 80204, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.